Drug Discovery Outsourcing Market Size, Top Share, Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Drug Discovery Outsourcing Market Size Analysis

Global Drug Discovery Outsourcing Market Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value

North America Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value
U.S.
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Target Identification & Screening
    1. By Value
  3. Target Validation & Functional Informatics
    1. By Value
  4. Lead Identification & Candidate Optimization
    1. By Value
  5. Preclinical Development
    1. By Value
  6. Other Associated Workflow
    1. By Value
2. By Therapeutics Area
  1. Introduction
    1. Therapeutics Area By Value
  2. Respiratory System
    1. By Value
  3. Pain and Anesthesia, Oncology
    1. By Value
  4. Ophthalmology
    1. By Value
  5. Hematology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrine
    1. By Value
  8. Gastrointestinal
    1. By Value
  9. Immunomodulation
    1. By Value
  10. Anti-Infective
    1. By Value
  11. Central Nervous System
    1. By Value
  12. Dermatology
    1. By Value
  13. Genitourinary System
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecules
    1. By Value
  3. Large Molecules (Biopharmaceuticals)
    1. By Value
Canada

Europe Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value
U.K.
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Target Identification & Screening
    1. By Value
  3. Target Validation & Functional Informatics
    1. By Value
  4. Lead Identification & Candidate Optimization
    1. By Value
  5. Preclinical Development
    1. By Value
  6. Other Associated Workflow
    1. By Value
2. By Therapeutics Area
  1. Introduction
    1. Therapeutics Area By Value
  2. Respiratory System
    1. By Value
  3. Pain and Anesthesia, Oncology
    1. By Value
  4. Ophthalmology
    1. By Value
  5. Hematology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrine
    1. By Value
  8. Gastrointestinal
    1. By Value
  9. Immunomodulation
    1. By Value
  10. Anti-Infective
    1. By Value
  11. Central Nervous System
    1. By Value
  12. Dermatology
    1. By Value
  13. Genitourinary System
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecules
    1. By Value
  3. Large Molecules (Biopharmaceuticals)
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value
China
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Target Identification & Screening
    1. By Value
  3. Target Validation & Functional Informatics
    1. By Value
  4. Lead Identification & Candidate Optimization
    1. By Value
  5. Preclinical Development
    1. By Value
  6. Other Associated Workflow
    1. By Value
2. By Therapeutics Area
  1. Introduction
    1. Therapeutics Area By Value
  2. Respiratory System
    1. By Value
  3. Pain and Anesthesia, Oncology
    1. By Value
  4. Ophthalmology
    1. By Value
  5. Hematology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrine
    1. By Value
  8. Gastrointestinal
    1. By Value
  9. Immunomodulation
    1. By Value
  10. Anti-Infective
    1. By Value
  11. Central Nervous System
    1. By Value
  12. Dermatology
    1. By Value
  13. Genitourinary System
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecules
    1. By Value
  3. Large Molecules (Biopharmaceuticals)
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value
UAE
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Target Identification & Screening
    1. By Value
  3. Target Validation & Functional Informatics
    1. By Value
  4. Lead Identification & Candidate Optimization
    1. By Value
  5. Preclinical Development
    1. By Value
  6. Other Associated Workflow
    1. By Value
2. By Therapeutics Area
  1. Introduction
    1. Therapeutics Area By Value
  2. Respiratory System
    1. By Value
  3. Pain and Anesthesia, Oncology
    1. By Value
  4. Ophthalmology
    1. By Value
  5. Hematology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrine
    1. By Value
  8. Gastrointestinal
    1. By Value
  9. Immunomodulation
    1. By Value
  10. Anti-Infective
    1. By Value
  11. Central Nervous System
    1. By Value
  12. Dermatology
    1. By Value
  13. Genitourinary System
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecules
    1. By Value
  3. Large Molecules (Biopharmaceuticals)
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Target Identification & Screening
  1. By Value
3. Target Validation & Functional Informatics
  1. By Value
4. Lead Identification & Candidate Optimization
  1. By Value
5. Preclinical Development
  1. By Value
6. Other Associated Workflow
  1. By Value
By Therapeutics Area
1. Introduction
  1. Therapeutics Area By Value
2. Respiratory System
  1. By Value
3. Pain and Anesthesia, Oncology
  1. By Value
4. Ophthalmology
  1. By Value
5. Hematology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrine
  1. By Value
8. Gastrointestinal
  1. By Value
9. Immunomodulation
  1. By Value
10. Anti-Infective
  1. By Value
11. Central Nervous System
  1. By Value
12. Dermatology
  1. By Value
13. Genitourinary System
  1. By Value
By Drug Type
1. Introduction
  1. Drug Type By Value
2. Small Molecules
  1. By Value
3. Large Molecules (Biopharmaceuticals)
  1. By Value
Brazil
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Target Identification & Screening
    1. By Value
  3. Target Validation & Functional Informatics
    1. By Value
  4. Lead Identification & Candidate Optimization
    1. By Value
  5. Preclinical Development
    1. By Value
  6. Other Associated Workflow
    1. By Value
2. By Therapeutics Area
  1. Introduction
    1. Therapeutics Area By Value
  2. Respiratory System
    1. By Value
  3. Pain and Anesthesia, Oncology
    1. By Value
  4. Ophthalmology
    1. By Value
  5. Hematology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrine
    1. By Value
  8. Gastrointestinal
    1. By Value
  9. Immunomodulation
    1. By Value
  10. Anti-Infective
    1. By Value
  11. Central Nervous System
    1. By Value
  12. Dermatology
    1. By Value
  13. Genitourinary System
    1. By Value
3. By Drug Type
  1. Introduction
    1. Drug Type By Value
  2. Small Molecules
    1. By Value
  3. Large Molecules (Biopharmaceuticals)
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Drug Discovery Outsourcing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Curia
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
EVOTEC
Laboratory Corporation of America Holdings
GenScript
Pharmaceutical Product Development LLC
Charles River Laboratories
Thermo Fischer ScientificInc.
Merck & Co.Inc.
Oncodesign
Jubilant Biosys.
Qiagen and Discover Corporation.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment